Are voters still wary of ‘Big Pharma?’
President Trump intends to find out with a new digital ad blitz that casts his Democratic opponent, former vice president Joe Biden, as the drug industry’s preferred candidate in November.
As STAT’s Lev Facher reports, Trump’s ads on Facebook and Instagram tout the president’s plans for lowering out-of-pocket drug costs and paint Biden as a friend to the industry. “That’s why Big Pharma is attacking President Trump,” one ad reads. “They liked it better with Joe Biden when health care costs SKYROCKETED.”
To say nothing of Trump’s mixed record on actually addressing drug prices, it’s unclear whether railing against pharma is the electoral red meat it once was. The rising cost of medicine is one of many political issues blotted out by the Covid-19 crisis. And the race to develop a vaccine for the novel coronavirus, which Trump has promised as early as Election Day, is reliant on the very companies he’s criticizing, making for something of a mixed message.
Read more.
As STAT’s Lev Facher reports, Trump’s ads on Facebook and Instagram tout the president’s plans for lowering out-of-pocket drug costs and paint Biden as a friend to the industry. “That’s why Big Pharma is attacking President Trump,” one ad reads. “They liked it better with Joe Biden when health care costs SKYROCKETED.”
To say nothing of Trump’s mixed record on actually addressing drug prices, it’s unclear whether railing against pharma is the electoral red meat it once was. The rising cost of medicine is one of many political issues blotted out by the Covid-19 crisis. And the race to develop a vaccine for the novel coronavirus, which Trump has promised as early as Election Day, is reliant on the very companies he’s criticizing, making for something of a mixed message.
Read more.
No hay comentarios:
Publicar un comentario